allogeneic mesenchymal stem cells: Clinical Trials

4 trials of allogeneic mesenchymal stem cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Active not recruiting 1, Recruiting 1
Phase 22Active not recruiting 1, Completed 1

Follow allogeneic mesenchymal stem cells: new trials by email Literature Review of allogeneic mesenchymal stem cells trials Research Report on allogeneic mesenchymal stem cells

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old
allogeneic mesenchymal stem cells, Placebo - Urinary Incontinence Stress
Phase 1RecruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz602024-12-162025-05-01
Stem Cell and Conditioned Medium for Cerebral Palsy
Umbilical Cord Mesenchymal Stem Cells, Conditioned Medium, Standard Therapy - Cerebral Palsy
Phase 1 / Phase 2Active not recruitingPT. Prodia Stem Cell Indonesia782021-10-132026-02-25
Stem Cell Injection in Cancer Survivors
Allo-MSCs, Placebo - Cardiomyopathy Due to Anthracyclines
Phase 1CompletedThe University of Texas Health Science Center, Houston462016-08-012020-11-05
Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Allogeneic mesenchymal stem cells, Polyurethene Film - Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2CompletedAnterogen Co., Ltd.22015-12-082023-08-25

Conditions studied

Breast Neoplasms (1)  ·  Cardiomyopathies (1)  ·  Cerebral Palsy (1)  ·  Epidermolysis Bullosa (1)  ·  Epidermolysis Bullosa Dystrophica (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Sarcoma (1)  ·  Urinary Incontinence, Stress (1)

Sponsors

Anterogen Co., Ltd. (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)  ·  PT. Prodia Stem Cell Indonesia (1)  ·  The University of Texas Health Science Center, Houston (1)

Countries

Indonesia (1)  ·  South Korea (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Robert Simari, MD (1)  ·  Su Chan Kim, PhD. (1)

NIH funding

5UM1HL087318 (1)